Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 646 of 1,261
  1. US 9585954

    Mucosal immunization

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  2. US 9585935

    Intranasal oxytocin treatment to improve schizophrenia

    The Regents of the University of California · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  3. US 9585936

    Method for therapeutic replenishment and enrichment of ocular surface lubrication

    The Regents of the University of California · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  4. US 9585882

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  5. US 9585910

    Polymers functionalized with ion-specific recognition elements

    The Board of Regents of the University of Texas System · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  6. US 9585878

    Treatment of BDNF-related disorders using laquinimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  7. US 9585874

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  8. US 9585838

    Production of multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  9. US 9587240

    Compositions and methods for inhibiting expression of a target gene

    Alnylam Pharmaceuticals, Inc. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  10. US 9587232

    Mutated organophosphorus acid anhydrolases and their uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  11. US 9587029

    Human antibodies to the glucagon receptor and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  12. US 9587008

    Method of producing recombinant vitamin K dependent proteins

    APTEVO BIOTHERAPEUTICS LLC · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  13. US 2017056477

    Dry Growth Hormone Composition Transiently Linked to a Polymer Carrier

    ASCENDIS PHARMA GROWTH DISORDERS DIV AS [DK] · Granted Mar 2, 2017 · Expires Feb 25, 2037

    granted
  14. US 9580427

    Kinase inhibitors

    The Regents of the University of California · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  15. US 9579407

    Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals

    Takeda Pharmaceutical Company Limited · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  16. US 9579316

    Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities

    Almirall, S.A. · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  17. US 9579302

    Ketone bodies to protect tissues from damage by ionizing radiation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  18. US 9579324

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  19. US 9580438

    Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

    4SC DISCOVERY GMBH · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  20. US 9580489

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  21. US 9579394

    Polyanion nanocomplexes for therapeutic applications

    UNIVERSITAET REGENSBURG · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  22. US 9579346

    Treatment of macrophage-related disorders

    The Regents of the University of California · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  23. US 9579392

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Nektar Therapeutics · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  24. US 9579333

    Inhibition of HIV infection through chemoprophyalxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.